A phase 1b study of abemaciclib, an inhibitor of CDK4 and CDK6, in combination with endocrine and HER2-targeted therapies for patients with metastatic breast cancer

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Beeram, M; Tolaney, SM; Beck, JT; Dickler, MN; Conlin, AK; Dees, C; Helsten, TL; Conkling, PR; Edenfield, WJ; Richards, DA; Kambhampati, SRP; Costigan, TM; Chan, E; Pant, S; Kalinsky, K; Burris, HA; Becerra, CH; Rexer, BN; Puhalla, SL; Goetz, MP

Published Date

  • October 1, 2016

Published In

Volume / Issue

  • 27 /

Published By


  • 1

Electronic International Standard Serial Number (EISSN)

  • 1569-8041

International Standard Serial Number (ISSN)

  • 0923-7534

Digital Object Identifier (DOI)

  • 10.1093/annonc/mdw435.8